These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2171373)

  • 1. Participation of phosphoinositides in gastric mucosal protection by colloidal bismuth subcitrate against ethanol-induced injury.
    Slomiany BL; Wang XY; Palecz D; Okazaki K; Slomiany A
    Alcohol Clin Exp Res; 1990 Aug; 14(4):580-3. PubMed ID: 2171373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sucralfate protection of gastric mucosa against alcohol-induced injury: a phosphoinositide mediated process.
    Slomiany BL; Mizuta K; Keogh J; Slomiany A
    Biochem Int; 1990; 21(3):555-62. PubMed ID: 2222498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric mucosal protection by sucralfate involves phosphoinositides participation.
    Slomiany A; Mizuta K; Piotrowski J; Nishikawa H; Slomiany BL
    Int J Biochem; 1990; 22(10):1179-83. PubMed ID: 1963155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric mucosa protective effects of colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Int J Tissue React; 1987; 9(5):427-32. PubMed ID: 3478321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric mucosa protection and prostaglandin E2 generation in rats by colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):308-19. PubMed ID: 3473983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic evaluation of gastric mucosal protection by colloidal bismuth subcitrate (De-Nol).
    van den Hoven WE; Birtwhistle RD; Hall DW
    Int J Tissue React; 1988; 10(5):297-304. PubMed ID: 3250943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective properties of colloidal bismuth subcitrate on gastric mucosa.
    Hall DW; van den Hoven WE
    Scand J Gastroenterol Suppl; 1986; 122():11-3. PubMed ID: 3465026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inability of cytoprotection to occur during a period of gastric ischemia.
    Frydman GM; Penney AG; Malcontenti C; O'Brien PE
    Dig Dis Sci; 1991 Oct; 36(10):1353-60. PubMed ID: 1914755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the protective qualities of gastric mucus by sucralfate: role of phosphoinositides.
    Slomiany BL; Piotrowski J; Tamura S; Slomiany A
    Am J Med; 1991 Aug; 91(2A):30S-36S. PubMed ID: 1715671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against alcohol-induced gastric mucosal injury by geranylgeranylacetone: effect of indomethacin.
    Bilski J; Murty VL; Nadziejko C; Sarosiek J; Aono M; Moriga M; Slomiany A; Slomiany BL
    Digestion; 1988; 41(1):22-33. PubMed ID: 3203824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts.
    Bagchi D; Carryl OR; Tran MX; Bagchi M; Vuchetich PJ; Krohn RL; Ray SD; Mitra S; Stohs SJ
    Dig Dis Sci; 1997 Sep; 42(9):1890-900. PubMed ID: 9331152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate.
    Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
    Scand J Gastroenterol Suppl; 1986; 122():6-10. PubMed ID: 3465028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: gastric mucosal blood flow after CBS treatment.
    Eleftheriadis E; Kotzampassi K; Tzartinoglou E; Salem A; Aletras H
    Gastroenterol Jpn; 1991 Jun; 26(3):283-6. PubMed ID: 1889688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement in gastric mucus gel qualities with colloidal bismuth subcitrate administration.
    Piotrowski J; Bilski J; Nishikawa H; Slomiany A; Slomiany BL
    Eur J Pharmacol; 1990 Aug; 184(1):55-63. PubMed ID: 2209715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated colloidal bismuth subcitrate treatment on the response of the rat gastric mucosa to the presence of luminal ethanol.
    Hinsull SM; Bellamy D
    Gut; 1990 Apr; 31(4):389-96. PubMed ID: 2338263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of putative cytoprotective properties of antiulcer drugs using quantitative histological techniques.
    O'Brien PE; Frydman G; Holmes R; Malcontenti C; Phelan D
    Dig Dis Sci; 1990 Sep; 35(9):1130-9. PubMed ID: 2390928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress, diet and alcohol-induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate.
    Bagchi D; Carryl OR; Tran MX; Krohn RL; Bagchi DJ; Garg A; Bagchi M; Mitra S; Stohs SJ
    J Appl Toxicol; 1998; 18(1):3-13. PubMed ID: 9526828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the modes of action of colloidal bismuth subcitrate.
    Hall DW
    Scand J Gastroenterol Suppl; 1989; 157():3-6; discussion 21-2. PubMed ID: 2665050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bismuth subcitrate and sucralfate on rat duodenal and human gastric bicarbonate secretion in vivo.
    Shorrock CJ; Garner A; Hunter AH; Crampton JR; Rees WD
    Gut; 1990 Jan; 31(1):26-31. PubMed ID: 2318428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of colloidal bismuth subcitrate on age related gastric lesions in the rat.
    Hinsull SM
    Gut; 1991 Apr; 32(4):355-60. PubMed ID: 2026333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.